Abstract
Anti-U1RNP antibody is associated with distinct organ involvement in patients with systemic lupus erythematosus (SLE). Nailfold capillaroscopy (NFC) allows non-invasive assessment of microvascular abnormalities in several connective tissue diseases. The objective of this study is to determine the association of anti-U1RNP antibody with microvascular changes by NFC in RNP-positive SLE patients in comparison with RNP-negative SLE patients (negative disease controls) and mixed connective tissue disease (MCTD) cases (positive disease controls). NFC examination was performed in consecutive patients with SLE with or without anti-U1RNP positivity. MCTD patients were recruited as disease controls. Abnormalities noted in the three groups were compared using non-parametric tests. Ordinal logistic or linear regression was used wherever applicable. 81 patients were studied, of whom 28 were diagnosed as RNP-positive SLE (age 30.0 ± 10.37; 26 females), 26 were RNP-negative SLE (age 29.42 ± 9.20; 25 females) and 27 had MCTD (age36.5 ± 9.70; 25 females). RNP-positive SLE patients had more frequent giant capillaries, enlarged capillaries and ramified capillaries as compared to RNP-negative SLE (p = 0.05, < 0.01 and 0.03, respectively). The capillary density was lower in patients with MCTD as compared with patients with RNP-positive SLE (5.11 ± 1.69/mm vs 7.25 ± 1.38/ mm, p < 0.01) and RNP-negative SLE (8.92 ± 1.13/mm, p < 0.01). The reduction in capillary density was less severe in patients with RNP-negative SLE as compared with RNP-positive SLE (OR = 0.1058 [95% CI = 0.02–0.546], p < 0.01) which was independent of the presence of Raynaud’s phenomenon, interstitial lung disease and disease duration. Presence of anti-U1RNP antibody is associated with notable patterns of microvascular abnormalities in SLE. These NFC abnormalities are noted more profoundly in patients with MCTD and are less marked in RNP-negative SLE patients.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available on request from the 1st author and the corresponding author.
References
Benito-Garcia E, Schur PH, Lahita R (2004) American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-Sm and anti-RNP antibody tests. Arthritis Rheum 51(6):1030–44. https://doi.org/10.1002/art.20836 (PMID: 15593352)
Hoffman IE, Peene I, Meheus L, Huizinga TW, Cebecauer L, Isenberg D, De Bosschere K, Hulstaert F, Veys EM, De Keyser F (2004) Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis 63(9):1155–1158. https://doi.org/10.1136/ard.2003.013417 (PMID:15308527;PMCID:PMC1755119)
Huang C, Li M, Liu Y, Wang Q, Guo X, Zhao J, Lai J, Tian Z, Zhao Y, Zeng X (2016) Baseline characteristics and risk factors of pulmonary arterial hypertension in systemic lupus erythematosus patients. Med (Baltim) 95(10):e2761. https://doi.org/10.1097/MD.0000000000002761 (PMID:26962774;PMCID:PMC4998855)
Cutolo M, Smith V (2013) State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology? Rheumatol (Oxf) 52(11):1933–1940. https://doi.org/10.1093/rheumatology/ket153 (Epub 2013 Apr 25 PMID: 23620555)
Maricq HR, LeRoy EC (1973) Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum 16(5):619–28. https://doi.org/10.1002/art.1780160506 (PMID: 4742842)
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. https://doi.org/10.1002/art.1780400928 (PMID: 9324032)
Alarcón-Segovia D, Cardiel MH (1989) Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol. 16(3):328–34 (PMID: 2724251)
Dinsdale G, Moore T, O’Leary N, Tresadern P, Berks M, Roberts C, Manning J, Allen J, Anderson M, Cutolo M, Hesselstrand R, Howell K, Pizzorni C, Smith V, Sulli A, Wildt M, Taylor C, Murray A, Herrick AL (2017) Intra-and inter-observer reliability of nailfold videocapillaroscopy—a possible outcome measure for systemic sclerosis-related microangiopathy. Microvasc Res 112:1–6. https://doi.org/10.1016/j.mvr.2017.02.001 (Epub 2017 Feb 2 PMID: 28163035)
Sulli A, Secchi ME, Pizzorni C, Cutolo M (2008) Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 67(6):885–887. https://doi.org/10.1136/ard.2007.079756 (Epub 2007 Nov 23 PMID: 18037628)
EtehadTavakol M, Fatemi A, Karbalaie A, Emrani Z, Erlandsson BE (2015) Nailfold capillaroscopy in rheumatic diseases: which parameters should be evaluated? Biomed Res Int 2015:974530. https://doi.org/10.1155/2015/974530 (Epub 2015 Sep 1. PMID: 26421308; PMCID: PMC4569783)
Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27(1):155–160 (PMID: 10648032)
Terreri MT, Andrade LE, Puccinelli ML, Hilário MO, Goldenberg J (1999) Nail fold capillaroscopy: normal findings in children and adolescents. Semin Arthritis Rheum 29(1):36–42. https://doi.org/10.1016/s0049-0172(99)80036-5 (PMID: 10468413)
Ingegnoli F, Gualtierotti R, Lubatti C, Zahalkova L, Meani L, Boracchi P, Zeni S, Fantini F (2009) Feasibility of different capillaroscopic measures for identifying nailfold microvascular alterations. Semin Arthritis Rheum 38(4):289–295. https://doi.org/10.1016/j.semarthrit.2007.10.008 (Epub 2007 Dec 31 PMID: 18166220)
Kabasakal Y, Elvins DM, Ring EF, McHugh NJ (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55(8):507–512. https://doi.org/10.1136/ard.55.8.507.PMID:8774177;PMCID:PMC1010229
Lambova SN, Muller-Ladner U (2018) Nailfold capillaroscopy within and beyond the scope of connective tissue diseases. CurrRheumatol Rev 14(1):12–21. https://doi.org/10.2174/1573397113666170615093600 (PMID: 28641551)
Cutolo M, Sulli A, Secchi ME, Paolino S, Nailfold Pizzorni C (2006) capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatol (Oxf). 45(Suppl 4):43–6. https://doi.org/10.1093/rheumatology/kel310 (PMID: 16980724)
Furtado RN, Pucinelli ML, Cristo VV, Andrade LE, Sato EI (2002) Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud’s phenomenon in SLE patients. Lupus 11(1):35–41. https://doi.org/10.1191/0961203302lu144oa (PMID: 11899953)
Keith MP, Moratz C, Tsokos GC (2007) Anti-RNP immunity: implications for tissue injury and the pathogenesis of connective tissue disease. Autoimmun Rev 6(4):232–236. https://doi.org/10.1016/j.autrev.2006.08.007 (Epub 2006 Aug 28 PMID: 17317614)
Sapkota B, Al Khalili Y. (2021) Mixed Connective Tissue Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID: 31194355
Casciola-Rosen L, Wigley F, Rosen A (1997) Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. J Exp Med 185(1):71–79. https://doi.org/10.1084/jem.185.1.71 (PMID:8996243;PMCID:PMC2196102)
Greidinger EL, Casciola-Rosen L, Morris SM, Hoffman RW, Rosen A (2000) Autoantibody recognition of distinctly modified forms of the U1–70-kd antigen is associated with different clinical disease manifestations. Arthritis Rheum 43(4):881–888. https://doi.org/10.1002/1529-0131(200004)43:4%3c881::AID-ANR20%3e3.0.CO;2-G (PMID: 10765934)
Negoro N, Kanayama Y, Takeda T, Amatsu K, Koda S, Inoue Y, Kim T, Okamura M, Inoue T (1987) Clinical significance of U1-RNP immune complexes in mixed connective tissue disease and systemic lupus erythematosus. Rheumatol Int 7(1):7–11. https://doi.org/10.1007/BF00267336 (PMID: 2954202)
Halla JT, Volanakis JE, Schrohenloher RE (1979) Circulating immune complexes in mixed connective tissue disease. Arthritis Rheum 22(5):484–489. https://doi.org/10.1002/art.1780220507 (PMID: 375940)
Okawa-Takatsuji M, Aotsuka S, Fujinami M, Uwatoko S, Kinoshita M, Sumiya M (1999) Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein. Clin Exp Immunol 116(1):174–180. https://doi.org/10.1046/j.1365-2249.1999.00864.x.PMID:10209523;PMCID:PMC1905219
Donnarumma JFS, Ferreira EVM, Ota-Arakaki J, Kayser C (2019) Nailfold capillaroscopy as a risk factor for pulmonary arterial hypertension in systemic lupus erythematosus patients. Adv Rheumatol 59(1):1. https://doi.org/10.1186/s42358-018-0045-5 (PMID: 30657102)
Cutolo M, Herrick AL, Distler O, Becker MO, Beltran E, Carpentier P, Ferri C, Inanç M, Vlachoyiannopoulos P, Chadha-Boreham H, Cottreel E, Pfister T, Rosenberg D, Torres JV, Smith V, CAP Study Investigators (2016) Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter prospective cohort study. Arthritis Rheumatol 68(10):2527–39. https://doi.org/10.1002/art.39718 (PMID: 27111549; PMCID: PMC5129545)
Carlucci PM, Purmalek MM, Dey AK, Temesgen-Oyelakin Y, Sakhardande S, Joshi AA, Lerman JB, Fike A, Davis M, Chung JH, Playford MP, Naqi M, Mistry P, Gutierrez-Cruz G, Dell’Orso S, Naz F, Salahuddin T, Natarajan B, Manna Z, Tsai WL, Gupta S, Grayson P, Teague H, Chen MY, Sun HW, Hasni S, Mehta NN, Kaplan MJ (2018) Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus. JCI Insight 3(8):e99276. https://doi.org/10.1172/jci.insight.99276.PMID:29669944;PMCID:PMC5931124
Kello N, Khoury LE, Marder G, Furie R, Zapantis E, Horowitz DL (2019) Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature. Semin Arthritis Rheum 49(1):74–83. https://doi.org/10.1016/j.semarthrit.2018.11.005 (Epub 2018 Dec 4 PMID: 30598332)
Pope J (2008) An update in pulmonary hypertension in systemic lupus erythematosus-do we need to know about it? Lupus 17(4):274–277. https://doi.org/10.1177/0961203307087188 (PMID: 18413406)
Funding
This work was supported by the intramural grant to Pramod Prahlad Chebbi from Christian Medical College Vellore
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No conflicts of interest.
Ethics approval
Obtained from institutional research board (ethics committee) CMC Vellore.
Informed consent
Written consent was obtained from the participants.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chebbi, P.P., Goel, R., Ramya, J. et al. Nailfold capillaroscopy changes associated with anti-RNP antibodies in systemic lupus erythematosus. Rheumatol Int 42, 1355–1361 (2022). https://doi.org/10.1007/s00296-021-04894-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-021-04894-4